Chewy (CHWY) Is Down 6.9% After Expanding Into Veterinary Services And Healthcare Offerings

Chewy

Chewy

CHWY

0.00

  • In recent months, Chewy has broadened its higher-margin healthcare and private-label offerings, including acquiring veterinary clinic operator Modern Animal to expand its pet health footprint.
  • This push into services and owned brands marks a shift in Chewy’s business mix that could be increasingly important for its long-term profitability profile.
  • We’ll now examine how Chewy’s expansion into veterinary services and healthcare could influence its existing investment narrative and future expectations.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Chewy Investment Narrative Recap

To own Chewy, you need to believe its Autoship-centric e-commerce model can translate a sticky customer base into improving margins, even as growth in new customers remains modest. The Modern Animal acquisition supports the view that higher-margin healthcare and services could become a more meaningful earnings driver over time. The biggest near term catalyst is progress in vet services and healthcare profitability, while a key risk remains whether these newer initiatives can offset pressure on margins and slowing customer growth. Overall, the recent news reinforces the existing story rather than changing it.

Among recent developments, Chewy’s acquisition of Modern Animal is most relevant here. It directly ties into the push to expand Chewy Vet Care and healthcare offerings, an area analysts already highlight as important for revenue diversification and potential margin improvement. How efficiently Chewy integrates and scales these clinics will likely influence whether its long term adjusted EBITDA margin ambitions remain realistic, or whether cost and execution risks begin to weigh more heavily on the thesis.

But investors should also be aware that if Chewy’s new services fail to gain traction...

Chewy's narrative projects $15.9 billion revenue and $623.4 million earnings by 2029. This implies 8.1% yearly revenue growth and about a $400.6 million earnings increase from $222.8 million today.

Uncover how Chewy's forecasts yield a $40.77 fair value, a 72% upside to its current price.

Exploring Other Perspectives

CHWY 1-Year Stock Price Chart
CHWY 1-Year Stock Price Chart

Some analysts are far more optimistic, assuming Chewy could reach about US$16.8 billion in revenue and US$778.6 million in earnings by 2029, which contrasts sharply with concerns about rising acquisition costs and competition and suggests the new vet and healthcare moves might eventually push these narratives in very different directions.

Explore 6 other fair value estimates on Chewy - why the stock might be worth just $40.77!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Chewy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Chewy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chewy's overall financial health at a glance.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

  • Find 51 companies with promising cash flow potential yet trading below their fair value.
  • We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • The latest GPUs need a type of rare earth metal called Neodymium and there are only 33 companies in the world exploring or producing it. Find the list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.